1,702
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies

, , , , , , , , , & show all
Pages 11-20 | Received 17 Jan 2014, Accepted 12 Mar 2014, Published online: 20 May 2014